191 related articles for article (PubMed ID: 38154422)
1. Costs and healthcare utilisation due to respiratory syncytial virus disease in paediatric patients in Italy: a systematic review.
Bechini A; Salvati C; Bonito B; Del Riccio M; Stancanelli E; Bruschi M; Ionita G; Iamarino JA; Bentivegna D; Buscemi P; Ciardi G; Cosma C; Stacchini L; Conticello C; Bega M; Paoli S; Schirripa A; Bertizzolo L; Muzii B; Azzi MV; Parisi S; Trippi F; Bonanni P; Boccalini S
Public Health; 2024 Feb; 227():103-111. PubMed ID: 38154422
[TBL] [Abstract][Full Text] [Related]
2. Clinical and economic burden of respiratory syncytial virus in children aged 0-5 years in Italy.
Dovizio M; Veronesi C; Bartolini F; Cavaliere A; Grego S; Pagliaro R; Procacci C; Ubertazzo L; Bertizzolo L; Muzii B; Parisi S; Perrone V; Baraldi E; Bozzola E; Mosca F; Esposti LD
Ital J Pediatr; 2024 Mar; 50(1):57. PubMed ID: 38528616
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus-associated hospitalizations among children: an Italian retrospective observational study.
Fortunato F; Campanozzi A; Maffei G; Arena F; Carri VD; Rollo T; Lopalco PL; Martinelli D
Ital J Pediatr; 2024 Mar; 50(1):45. PubMed ID: 38454523
[TBL] [Abstract][Full Text] [Related]
4. Burden of respiratory syncytial virus disease across the lifespan in Australia and New Zealand: a scoping review.
Farquharson KA; Anthony D; Menzies R; Homaira N
Public Health; 2024 Jan; 226():8-16. PubMed ID: 37980838
[TBL] [Abstract][Full Text] [Related]
5. Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children.
Garegnani L; Styrmisdóttir L; Roson Rodriguez P; Escobar Liquitay CM; Esteban I; Franco JV
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013757. PubMed ID: 34783356
[TBL] [Abstract][Full Text] [Related]
6. Estimating the economic burden of respiratory syncytial virus infections in infants in Vietnam: a cohort study.
Do LAH; Vodicka E; Nguyen A; Le TNK; Nguyen TTH; Thai QT; Pham VQ; Pham TU; Nguyen TN; Mulholland K; Cao MT; Le NTN; Tran AT; Pecenka C
BMC Infect Dis; 2023 Feb; 23(1):73. PubMed ID: 36747128
[TBL] [Abstract][Full Text] [Related]
7. Changes in the global hospitalisation burden of respiratory syncytial virus in young children during the COVID-19 pandemic: a systematic analysis.
Cong B; Koç U; Bandeira T; Bassat Q; Bont L; Chakhunashvili G; Cohen C; Desnoyers C; Hammitt LL; Heikkinen T; Huang QS; Markić J; Mira-Iglesias A; Moyes J; Nokes DJ; Ploin D; ; Seo E; Singleton R; Wolter N; Fu Yung C; Zar HJ; Feikin DR; Sparrow EG; ; Nair H; Li Y;
Lancet Infect Dis; 2024 Apr; 24(4):361-374. PubMed ID: 38141633
[TBL] [Abstract][Full Text] [Related]
8. Respiratory syncytial virus disease morbidity in Australian infants aged 0 to 6 months: a systematic review with narrative synthesis.
Self A; Van Buskirk J; Clark J; Cochrane JE; Knibbs L; Cass-Verco J; Gupta L
BMC Public Health; 2023 Dec; 23(1):2560. PubMed ID: 38129854
[TBL] [Abstract][Full Text] [Related]
9. Inpatient burden of respiratory syncytial virus in children ≤2 years of age in Germany: A retrospective analysis of nationwide hospitalization data, 2019-2022.
Wick M; Poshtiban A; Kramer R; Bangert M; Lange M; Wetzke M; Damm O
Influenza Other Respir Viruses; 2023 Nov; 17(11):e13211. PubMed ID: 38019702
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children.
Andabaka T; Nickerson JW; Rojas-Reyes MX; Rueda JD; Bacic Vrca V; Barsic B
Cochrane Database Syst Rev; 2013 Apr; (4):CD006602. PubMed ID: 23633336
[TBL] [Abstract][Full Text] [Related]
11. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.
Li Y; Wang X; Blau DM; Caballero MT; Feikin DR; Gill CJ; Madhi SA; Omer SB; Simões EAF; Campbell H; Pariente AB; Bardach D; Bassat Q; Casalegno JS; Chakhunashvili G; Crawford N; Danilenko D; Do LAH; Echavarria M; Gentile A; Gordon A; Heikkinen T; Huang QS; Jullien S; Krishnan A; Lopez EL; Markić J; Mira-Iglesias A; Moore HC; Moyes J; Mwananyanda L; Nokes DJ; Noordeen F; Obodai E; Palani N; Romero C; Salimi V; Satav A; Seo E; Shchomak Z; Singleton R; Stolyarov K; Stoszek SK; von Gottberg A; Wurzel D; Yoshida LM; Yung CF; Zar HJ; ; Nair H;
Lancet; 2022 May; 399(10340):2047-2064. PubMed ID: 35598608
[TBL] [Abstract][Full Text] [Related]
12. Economic burden of respiratory syncytial virus infection in adults: a systematic literature review.
Grace M; Colosia A; Wolowacz S; Panozzo C; Ghaswalla P
J Med Econ; 2023; 26(1):742-759. PubMed ID: 37167068
[TBL] [Abstract][Full Text] [Related]
13. Estimating the burden of respiratory syncytial virus (RSV) on respiratory hospital admissions in children less than five years of age in England, 2007-2012.
Reeves RM; Hardelid P; Gilbert R; Warburton F; Ellis J; Pebody RG
Influenza Other Respir Viruses; 2017 Mar; 11(2):122-129. PubMed ID: 28058797
[TBL] [Abstract][Full Text] [Related]
14. Clinical and economic hospital burden of acute respiratory infection (BARI) due to respiratory syncytial virus in Spanish children, 2015-2018.
Martinón-Torres F; Carmo M; Platero L; Drago G; López-Belmonte JL; Bangert M; Díez-Domingo J
BMC Infect Dis; 2023 Jun; 23(1):385. PubMed ID: 37291530
[TBL] [Abstract][Full Text] [Related]
15. Trends in hospitalizations of children with respiratory syncytial virus aged less than 1 year in Italy, from 2015 to 2019.
Cutrera R; d'Angela D; Orso M; Guadagni L; Vittucci AC; Bertoldi I; Polistena B; Spandonaro F; Carrieri C; Montuori EA; Iantomasi R; Orfeo L
Ital J Pediatr; 2024 Jun; 50(1):119. PubMed ID: 38902751
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis protects infants with congenital heart disease from severe forms of RSV infection: an Italian observational retrospective study : Palivizumab prophylaxis in children with congenital heart disease.
Ratti C; Greca AD; Bertoncelli D; Rubini M; Tchana B
Ital J Pediatr; 2023 Jan; 49(1):4. PubMed ID: 36631870
[TBL] [Abstract][Full Text] [Related]
17. Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis.
Zhang S; Akmar LZ; Bailey F; Rath BA; Alchikh M; Schweiger B; Lucero MG; Nillos LT; Kyaw MH; Kieffer A; Tong S; Campbell H; Beutels P; Nair H;
J Infect Dis; 2020 Oct; 222(Suppl 7):S680-S687. PubMed ID: 32227101
[TBL] [Abstract][Full Text] [Related]
18. Respiratory syncytial virus: can we still believe that after pandemic bronchiolitis is not a critical issue for public health?
Vittucci AC; Antilici L; Russo C; Musolino AMC; Cristaldi S; Cutrera R; Persia S; Di Maio CV; Raponi M; Perno CF; Villani A
Eur J Pediatr; 2023 Dec; 182(12):5303-5313. PubMed ID: 37728752
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection.
Sanders SL; Agwan S; Hassan M; Bont LJ; Venekamp RP
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD009417. PubMed ID: 37870128
[TBL] [Abstract][Full Text] [Related]
20. Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis.
Amand C; Tong S; Kieffer A; Kyaw MH
BMC Health Serv Res; 2018 Apr; 18(1):294. PubMed ID: 29678177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
